ZIVA 4.5 Injection | Piperacillin + Tazobactam For Severe Infections | Piperacillin Tazobactam Injection, IV Antibiotic, Broad-Spectrum Antibiotic, Severe Infection Treatment, Hospital Injection, Pneumonia Antibiotic, Diabetic Foot Infection, Postpartum Infection Treatment, Skin And Bone Infection Medicine

ZIVA 4.5 Injection is a powerful combination of Piperacillin Sodium (4gm) and Tazobactam (0.5gm) formulated to fight serious and resistant bacterial infections. This broad-spectrum IV antibiotic is highly effective against a wide range of gram-positive and gram-negative bacteria, making it a trusted solution for physicians treating life-threatening infections in hospital settings.

ZIVA 4.5 Injection delivers fast and targeted action, especially in conditions like community-acquired and hospital-acquired pneumonia, bone and joint infections, skin and soft tissue infections, diabetes-related foot infections, and postpartum endometritis. Its synergistic mechanism enhances the spectrum of activity, ensuring better outcomes in critical care.

✨ Key Benefits

✅  Rapid action against tough bacterial infections
✅  Broad-spectrum coverage (gram+ & gram– organisms)
✅  Effective in pneumonia, joint, skin, and diabetic foot infections
✅  Reduces risk of complications in post-surgical and postnatal infections
✅  Ideal for hospital and ICU use
✅  Backed by clinical efficacy and hospital trust

Key Ingredients

• Piperacillin Sodium (4gm) – A penicillin-class antibiotic that disrupts bacterial cell wall synthesis
• Tazobactam (0.5gm) – A β-lactamase inhibitor that prevents antibiotic resistance and enhances Piperacillin’s effect
  

  Why Choose ZIVA 4.5 Injection?

  ZIVA 4.5 Injection offers a clinically-proven solution to manage resistant infections with confidence. Its high-potency formulation is especially effective in emergency and ICU settings where fast recovery is critical. Manufactured under strict quality control by Riva Kenko Pharma, ZIVA 4.5 ensures purity, stability, and reliable performance. Whether for post-operative care, hospital-acquired infections, or severe systemic infections, ZIVA 4.5 Injection delivers the strength of dual-action protection that healthcare professionals rely on.